Portal de investigación
Plasma CD5L and non-invasive diagnosis of acute heart rejection.
Fecha de publicación:
Fecha Ahead of Print:
Autores de IIS La Fe
Participantes ajenos a IIS La Fe
- Corbacho-Alonso N
- G Barderas M
- Feijóo-Bandín S
Grupos
Abstract
Acute rejection is one of the most important direct contributors to mortality after heart transplantation. Advances in the development of novel non-invasive approaches for the early identification of allograft rejection are necessary. We conducted a non-targeted proteome characterization focused on identifying multiple plasmatic protein differences to evaluate their diagnostic accuracy for rejection episodes.
Datos de la publicación
- ISSN/ISSNe:
- 1053-2498, 1557-3117
- Tipo:
- Article
- Páginas:
- 257-266
- PubMed:
- 31883820
- Factor de Impacto:
- 3,549 SCImago ℠
- Cuartil:
- Q1 SCImago ℠
JOURNAL OF HEART AND LUNG TRANSPLANTATION ELSEVIER SCIENCE INC
Citas Recibidas en Web of Science: 18
Documentos
- No hay documentos
Filiaciones
Keywords
- ENDOMYOCARDIAL BIOPSY; INTERNATIONAL SOCIETY; SCIENTIFIC STATEMENT; TRANSPLANTATION; GUIDELINES; DISEASE; AIM
Campos de Estudio
Cita
TARAZÓN E,Corbacho N,Barderas GM,GIL C,GARCÍA M,Feijóo S,LAGO F,GONZÁLEZ JR,MARTÍNEZ L,PORTOLÉS M,ROSELLÓ E. Plasma CD5L and non-invasive diagnosis of acute heart rejection. J. Heart Lung Transplant. 2020. 39. (3):p. 257-266. IF:10,247. (1).